Effect of Ruboxistaurin on Clinically Significant Macular Edema

Clinical trial NCT00133952 · COMPLETED

Trial details

NCT number: NCT00133952
Sponsor: Chromaderm, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2005-08-01
Primary completion: 2011-07-01
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.